Discovery of a Small Molecule Tat-trans-Activation-responsive RNA Antagonist That Potently Inhibits Human Immunodeficiency Virus-1 Replication
Open Access
- 1 October 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (40) , 39092-39103
- https://doi.org/10.1074/jbc.m301749200
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Tat and Trans-activation-responsive (TAR) RNA-independent Induction of HIV-1 Long Terminal Repeat by Human and Murine Cyclin T1 Requires Sp1Published by Elsevier ,2003
- Neomycin B−Arginine Conjugate, a Novel HIV-1 Tat Antagonist: Synthesis and Anti-HIV ActivitiesBiochemistry, 2001
- HIV-1 TAR RNA Enhances the Interaction between Tat and Cyclin T1Journal of Biological Chemistry, 2000
- Tackling tatJournal of Molecular Biology, 1999
- Inhibitors of Protein−RNA Complexation That Target the RNA: Specific Recognition of Human Immunodeficiency Virus Type 1 TAR RNA by Small Organic MoleculesBiochemistry, 1998
- A Structural Basis for RNA−Ligand InteractionsChemical Reviews, 1997
- HIV-1 TAR RNA Recognition by an Unnatural BiopolymerJournal of the American Chemical Society, 1997
- Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesisJournal of the American Chemical Society, 1992
- Tat trans-activates the human immunodeficiency virus through a nascent RNA targetCell, 1989
- The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeatCell, 1985